ICPMS
Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Language Čeština

    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma | LabRulez ICPMS

    USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Sanofi-aventis - A high throughput assay for oxaliplatin in clinical samples

    Others
    | 2007 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Agilent ICP-MS Journal (August 2011 – Issue 47)

    Others
    | 2011 | Agilent Technologies
    ICP/MS, Speciation analysis
    Instrumentation
    ICP/MS, Speciation analysis
    Manufacturer
    Agilent Technologies
    Industries
    Environmental, Pharma & Biopharma

    Simplified QC for Pharmaceutical Elemental Impurity Analysis

    Others
    | 2017 | Agilent Technologies
    ICP/OES
    Instrumentation
    ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    ICP Expert Software Installation Instructions for 21 CFR Part 11 Environments

    Manuals
    | 2018 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Enterprise Content Manager (ECM)

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Analysis of Residual Catalysts in Pharmaceuticals Using ICP Atomic Emission Spectrometry

    Applications
    | 2010 | Shimadzu
    MP/ICP-AES
    Instrumentation
    MP/ICP-AES
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    WCPS: Single-Cell and Bulk ICP-MS Investigation of Accumulation Patterns of Pt-based Drugs in Cisplatin–Sensitive and –Resistant Cell Models

    Posters
    | 2023 | Agilent Technologies
    ICP/MS, ICP/MS/MS
    Instrumentation
    ICP/MS, ICP/MS/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma, Clinical Research

    Handbook of ICP-QQQ Applications using the Agilent 8800 and 8900

    Guides
    | 2022 | Agilent Technologies
    GC, HPLC, ICP/MS, Speciation analysis, ICP/MS/MS
    Instrumentation
    GC, HPLC, ICP/MS, Speciation analysis, ICP/MS/MS
    Manufacturer
    Agilent Technologies, Elemental Scientific
    Industries
    Environmental, Food & Agriculture, Energy & Chemicals , Pharma & Biopharma, Materials Testing, Semiconductor Analysis , Clinical Research
     

    Related content

    ‌

    Scientists continue to push the boundaries of imaging techniques and reveal the mysterious world of molecules

    Th, 25.4.2024
    Ústav organické chemie a biochemie AV ČR
    ‌

    Preventing early-onset colorectal cancers aim of $25 million award

    Tu, 23.4.2024
    Washington University in St. Louis
    ‌

    New Research Reveals Pesticide Mixtures Widespread in Environment, Urging Enhanced Regulatory Measures

    Mo, 22.4.2024
    RECETOX - Centrum pro výzkum toxických látek v prostředí
    ‌
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike